MedTrace Logo

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

NCT06775093 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2025-01-14

No results posted yet for this study

Summary

The goal of this clinical trial is to examine whether benalutide combined with metformin and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle education.

Conditions

  • Polycystic Ovary Syndrome
  • Obesity
  • Infertility, Female

Interventions

DRUG

GLP-1 receptor agonist

3 months

DRUG

Metformin

3 months

BEHAVIORAL

healthy lifestyle education

3 months

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06775093 on ClinicalTrials.gov